Verbatim response from Claude
This is a common situation, and compounded GLP-1s are one option, but here's an honest breakdown:
Compounded Semaglutide Options
Hims & Hers, Ro, LifeMD, Eden offer compounded semaglutide
- Typically $200-400/month
- Important caveat: FDA has indicated compounded semaglutide may soon be discontinued now that shortage designations have been lifted - availability is uncertain
Other Options Worth Trying First
Appeal your insurance denial
- Ask your doctor to write a letter of medical necessity
- Success rates can be meaningful, especially with documented obesity-related conditions
Manufacturer savings programs
- Novo Nordisk's "Wegovy Savings Card" can reduce costs significantly if you have commercial insurance
- Worth checking even after denial
Consider Zepbound (tirzepatide)
- May be covered when Wegovy isn't
- Eli Lilly's savings program can bring it to ~$550/month or less
Ozempic (off-label)
- Sometimes covered for diabetes even when Wegovy isn't
- Same active ingredient as Wegovy
My Honest Recommendation
Try Zepbound first - it's FDA-approved, often shows strong results, and Lilly's savings program is generous. Compounded is a backup option but comes with regulatory uncertainty right now.
Talk to your doctor about which path fits your situation.